Hydrogels loaded with MSC‐derived small extracellular vesicles: A novel cell‐free tissue engineering system for diabetic wound management
Weicheng Zhong,
No information about this author
Hao Meng,
No information about this author
Liqian Ma
No information about this author
et al.
View,
Journal Year:
2024,
Volume and Issue:
5(4)
Published: July 18, 2024
Abstract
With
the
aging
and
obesity
era,
increasing
incidence
of
diabetes
diabetic
complications,
especially
non‐healing
wounds,
imposes
a
serious
economic
burden
on
both
patients
society.
The
complex
microenvironments,
including
hyperglycemia,
bacterial
infection,
ischemia,
nerve
damage,
lead
to
prolonged
inflammation
proliferation
phase
wounds.
Mesenchymal
stem
cell‐derived
small
extracellular
vesicles
(MSC‐sEVs),
which
contain
rich
variety
therapeutic
molecules,
have
been
chased
for
decades
because
their
potential
roles
in
cellular
communication,
tissue
regeneration,
drug
delivery.
As
powerful
tools
controlled‐sustained
release
sEVs,
biocompatible
hydrogels
applied
wide
range
biomedical
applications.
Herein,
we
first
summarize
pathological
features
such
as
angiopathy,
neuropathy,
immune
cell
dysfunction.
Then,
discuss
biological
properties,
performance,
stability
pure
MSC‐sEVs.
After
that,
components,
application
patterns,
responsiveness
hydrogels.
Next,
loading
avenues
MSC‐sEVs
into
hydrogel,
behaviors
sEVs
from
hydrogels,
influence
crosslinking
method
hydrogel‐sEV
composites.
Finally,
provide
an
overview
current
applications
loaded
with
novel
cell‐free
engineering
system
managing
wounds
propose
critical
unsolved
issues.
This
review
is
expected
meaningful
guidance
developing
wound
management.
Language: Английский
The Rejuvenation and Functional Restoration of Aged Adipose Stem Cells by DUXAP10 Knockdown via the Regulation of the miR-214-3p/RASSF5 Axis
Sen Ren,
No information about this author
Chengcheng Li,
No information about this author
Hewei Xiong
No information about this author
et al.
Stem Cells Translational Medicine,
Journal Year:
2024,
Volume and Issue:
13(5), P. 462 - 476
Published: March 9, 2024
Abstract
Adipose
stem
cell
(ASC)-based
therapies
provide
an
encouraging
option
for
tissue
repair
and
regeneration.
However,
the
function
of
these
cells
declines
with
aging,
which
limits
their
clinical
transformation.
Recent
studies
have
outlined
involvement
long
non-coding
RNAs
in
aging.
Here,
we
reanalyzed
our
published
RNA
sequencing
(RNA-seq)
data
profiling
differences
between
ASCs
from
young
old
donors
identified
a
lncRNA
named
double
homeobox
A
pseudogene
10
(DUXAP10)
as
significantly
accumulated
aged
ASCs.
Knocking
down
DUXAP10
promoted
proliferation
migration
halted
senescence
secretion
proinflammatory
cytokines.
In
addition,
was
located
cytoplasm
functioned
decoy
miR-214-3p.
miR-214-3p
downregulated
ASCs,
its
overexpression
rejuvenated
reversed
harm
caused
by
DUXAP10.
Furthermore,
Ras
Association
Domain
Family
Member
5
(RASSF5)
target
upregulated
Overexpressing
inhibiting
both
enhanced
RASSF5
content
while
knockdown
therapeutic
ability
skin
wound
healing.
Overall,
this
study
offers
new
insights
into
mechanism
age-related
ASC
dysfunction
names
potential
targets
energizing
cells.
Language: Английский